Bicocca Open Archive

Logo unimib boa
PESCI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.023
EU - Europa 4.141
AS - Asia 1.146
AF - Africa 12
SA - Sud America 10
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 15.344
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.893
IT - Italia 870
DE - Germania 817
SE - Svezia 730
CN - Cina 678
IE - Irlanda 604
UA - Ucraina 320
GB - Regno Unito 221
HK - Hong Kong 211
FR - Francia 130
CA - Canada 128
AT - Austria 122
FI - Finlandia 116
VN - Vietnam 93
IN - India 66
DK - Danimarca 61
RU - Federazione Russa 55
TR - Turchia 36
BE - Belgio 30
NL - Olanda 19
ES - Italia 13
SG - Singapore 13
JP - Giappone 12
IR - Iran 9
RO - Romania 8
KR - Corea 7
CL - Cile 6
PK - Pakistan 6
AU - Australia 5
CH - Svizzera 4
GR - Grecia 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
SC - Seychelles 4
BD - Bangladesh 3
BR - Brasile 3
LB - Libano 3
NG - Nigeria 3
PL - Polonia 3
BG - Bulgaria 2
CZ - Repubblica Ceca 2
EU - Europa 2
IL - Israele 2
MU - Mauritius 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CR - Costa Rica 1
EE - Estonia 1
EG - Egitto 1
HU - Ungheria 1
ID - Indonesia 1
IQ - Iraq 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
MX - Messico 1
NO - Norvegia 1
PH - Filippine 1
RS - Serbia 1
TH - Thailandia 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 15.344
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.538
Fairfield 907
Woodbridge 862
Chandler 851
Frankfurt am Main 614
Dublin 586
Houston 576
Wilmington 548
Ashburn 498
Dearborn 351
Jacksonville 341
Seattle 337
New York 307
Cambridge 291
Princeton 240
Hong Kong 210
Milan 191
Nanjing 143
Vienna 120
Altamura 113
Lawrence 105
Shanghai 83
Beijing 70
San Diego 59
Lachine 56
Guangzhou 54
Boardman 53
Dong Ket 52
Nanchang 48
Fremont 42
Helsinki 41
Toronto 35
Andover 33
Hebei 33
Jinan 32
Shenyang 30
Brussels 29
Lissone 26
Jiaxing 24
Tianjin 24
London 19
Norwalk 19
Falls Church 18
Rome 18
Hangzhou 16
Lappeenranta 16
Brescia 15
Mountain View 15
Ottawa 15
Changsha 14
Los Angeles 14
Monza 14
Ningbo 14
Zhengzhou 13
Pune 12
Edmonton 11
Hefei 11
Kiev 9
Kocaeli 9
Desio 8
Genoa 8
Kunming 8
Tappahannock 8
Turin 8
Auburn Hills 7
Leawood 7
Washington 7
Ansbach 6
Bari 6
Groningen 6
Montréal 6
Orange 6
Phoenix 6
Redmond 6
Carate Brianza 5
Changchun 5
Chicago 5
Nürnberg 5
Padova 5
Paris 5
Sesto San Giovanni 5
Siena 5
Torre Annunziata 5
Upper Marlboro 5
Auckland 4
Bologna 4
Bonndorf 4
Busto Arsizio 4
Florence 4
Fuzhou 4
Hanoi 4
Kemerovo 4
Palermo 4
Suceava 4
Tokyo 4
Walnut 4
Wuhan 4
Xian 4
Abano Terme 3
Abuja 3
Totale 12.040
Salva come PNG Salva come JPEG
Nome #
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 321
Noninvasive ventilation weaning in acute hypercapnic respiratory failure due to COPD exacerbation: A real-life observational study 282
Progressive fibrosing interstitial lung diseases: prevalence and characterization in two Italian referral centers 273
Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights 272
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 265
Regional differences in bronchial reactivity assessed by respiratory impedance 213
Rehospitalization for pneumonia after first pneumonia admission: Incidence and predictors in a population-based cohort study 206
Dyspnea in crackling lungs 205
The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone 205
Response to: Comment on "Noninvasive Ventilation Weaning in Acute Hypercapnic Respiratory Failure due to COPD Exacerbation: A Real-Life Observational Study" 191
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study 188
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 185
162. Cluster analysis to explore clinical subclassification of eosinophilic granulomatosis with polyangiitis (churg–strauss) 184
Psychometric properties and minimal important differences of SF-36 in Idiopathic Pulmonary Fibrosis 183
Influenza A/H1N1 severe pneumonia: Novel morphocytological findings in bronchoalveolar lavage 182
Renal involvement in Churg-Strauss syndrome 181
Delirium symptoms during hospitalization predict long-term mortality in patients with severe pneumonia 180
Impact of traffic-related air pollution on pulmonary oxidative stress 178
Progression of obstructive ventilatory disorder in Fabry disease: Only a matter of time? 176
HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome 175
Diaphragm ultrasonography in the management of patients with amyotrophic lateral sclerosis 175
Corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A single center experience and literature review 175
Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration Is Essential 174
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases 172
Characterization of bronchiectasis in the elderly 172
Bronchoalveolar lavage in idiopathic pulmonary fibrosis: What does it tell us? 171
Cardiovascular autonomic alterations in hospitalized patients with community-acquired pneumonia 170
A 61-year-old female with chronic cough and purulent sputum 166
Alpha glucocorticoid receptor expression in different experimental rat models of acute lung injury 164
Il lavaggio broncoalveolare nelle pneumopatie infiltrative diffuse 164
C-arm cone-beam CT-guided transthoracic lung core needle biopsy as a standard diagnostic tool 163
Persistence with inhaled corticosteroids reduces the risk of exacerbation among adults with asthma: A real-world investigation 160
Pirfenidone in real life: A retrospective observational multicentre study in Italian patients with idiopathic pulmonary fibrosis 160
Prolonged exposure to welding fumes as a novel cause of systemic iron overload 159
A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary Fibrosis 158
Efficacy of pirfenidone for idiopathic pulmonary fibrosis: An Italian real life study 158
Multidimensional severity assessment in bronchiectasis: An analysis of seven European cohorts 157
Clinical phenotypes in adult patients with bronchiectasis 157
Management of acute respiratory failure in interstitial lung diseases: Overview and clinical insights 156
Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity 155
Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist 155
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 155
Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: Do we need a personalized approach? 153
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 153
Metallic elements in exhaled breath condensate of patients with interstitial lung diseases 150
Uterine carcinosarcoma metastatic to the lung as large-cell neuroendocrine carcinoma with synchronous sarcoid granulomatosis 149
Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy 145
An unusual presentation of pulmonary lymphoma: When diffuse ground glass opacities can mean anything 145
Systemic sclerosis and outcome in intensive care unit: Do not close the door, open the right protocol 143
Non-specific interstitial pneumonia and features of connective tissue disease: What are the consequences of a different point of view? 143
Interstitial pneumonia with autoimmune features: an additional risk factor for ARDS? 139
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis 139
COPD: maximization of bronchodilation 132
Can healthcare utilization data reliably capture cases of chronic respiratory diseases? A cross-sectional investigation in Italy 132
Auto-antibodies against type I IFNs in patients with life-threatening COVID-19 132
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study 129
Allergic bronchopulmonary aspergillosis screening in bronchiectasis: Is there always a precise answer to a clear question? 129
The management of community-acquired pneumonia in the elderly 124
Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis 123
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 123
Covid-19 and the role of smoking: The protocol of the multicentric prospective study COSMO-IT (covid19 and smoking in italy) 123
Respiratory system involvement in systemic vasculitides 120
Geriatric multidimensional assessment for elderly patients with acute respiratory diseases 120
The bronchiectasis severity index. An international derivation and validation study 120
Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis 119
A case of ARDS associated with influenza A - H1N1 infection treated with extracorporeal respiratory support 117
Interstitial lung diseases in a lung cancer screening trial 117
Macrolidi a lungo termine nella broncopneumopatia cronica ostruttiva 115
History of lung volume reduction procedures 115
Clinical course of IPF in Italian patients during 12 months of observation: results from the FIBRONET observational study 114
Optimization of ventilator setting by flow and pressure waveforms analysis during noninvasive ventilation for acute exacerbations of COPD: a multicentric randomized controlled trial 113
Alveolar Diseases 112
Economic impact of anti-IL-5 agents in patients with severe eosinophilic asthma: A population-based cohort study 110
Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial 110
Fcγ-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitis 109
Respiratory system involvement in ANCA-associated systemic vasculitides 106
Non-tuberculous Mycobacterial Pulmonary Disease: an Italian National Survey 104
Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study 104
Bronchoalveolar lavage in intensive care units 103
Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumonia 102
Cryoglobulinemia 101
Outcome and prognostic factors during the course of primary small-vessel vasculitides 100
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study 100
Cystic Diseases 98
Reticular Diseases 97
Right ventricular reverse remodelling in Idiopathic Pulmonary Arterial Hypertension diagnosed during pregnancy: Is it possible? 96
Acute myocardial infarction versus other cardiovascular events in communityacquired pneumonia 96
Long-term macrolides in diffuse interstitial lung diseases 93
The European IPF registry (eurIPFreg): Baseline characteristics and survival of patients with idiopathic pulmonary fibrosis 93
Interferon gamma e fibrosi polmonare idiopatica 92
Surgical and endoscopic treatment for COPD: Patients selection, techniques and results 92
Respiratory System Involvement in Antineutrophil Cytoplasmic-associated Vasculitides: Clinical, pathological, radiological and therapeutic considerations 91
EBUS-TBNA nella patologia mediastino-polmonare: analisi retrospettiva dei primi 3 anni di attività di un singolo centro 91
Pneumopatie Infiltrative Diffuse 86
Nodular Diseases 85
Molecular biomarkers in idiopathic pulmonary fibrosis: State of the art and future directions 85
Effect of recombinant human pentraxin 2 vs placebo on change in forced vital capacity in patients with idiopathic pulmonary fibrosis a randomized clinical trial 84
Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective 80
Granulomatous lung disease 79
Differences between acute exacerbations of idiopathic pulmonary fibrosis and other interstitial lung diseases 76
Totale 14.392
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.155
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.155
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019555 0 0 0 0 0 0 0 0 0 0 247 308
2019/20202.900 374 179 191 235 279 374 378 220 254 185 152 79
2020/20213.017 112 111 256 348 281 265 291 346 281 312 169 245
2021/20221.968 194 206 232 210 109 161 65 95 75 140 156 325
2022/20233.101 347 865 350 289 186 471 36 179 215 22 82 59
2023/20241.729 52 61 107 97 247 551 367 90 122 33 2 0
Totale 16.026